Company: MDCXW
Filing Date: 2025-09-29
Form Type: S-1
Source: 0001062993-25-015841
Chunk: 80

Company: Medicus Pharma Ltd.
Filing Date: 2025-09-29
Form: S-1
Chunk 80
---
 per share and will expire on June 2, 2030. As of June 30, 2025 no warrants have been exercised for cash.

Results of Operations

The following table outlines our statements of loss and comprehensive loss for the three and six months ended June 30, 2025 and 2024:

|                                               |     | Three months ended June 30, 
                        2025 |   |     |       2024 |   |     |            |   |     | Six months ended June 30, 
                      2025 |   |     |       2024 |   |     |            |   |
|:----------------------------------------------|:----|----------------------------:|:--|:----|-----------:|:--|:----|-----------:|:--|:----|--------------------------:|:--|:----|-----------:|:--|:----|-----------:|:--|
|                                               |     |                           $ |   |     |          $ |   |     |     Change |   |     |                         $ |   |     |          $ |   |     |     Change |   |
| General and administrative                    |     |                   4,576,524 |   |     |  2,276,676 |   |     |  2,299,848 |   |     |                 7,696,584 |   |     |  3,662,657 |   |     |  4,033,927 |   |
| Research and development                      |     |                   1,439,564 |   |     |  1,277,158 |   |     |    162,406 |   |     |                 3,445,778 |   |     |  1,598,535 |   |     |  1,847,243 |   |
| Total operating expenses                      |     |                   6,016,088 |   |     |  3,553,834 |   |     |  2,462,254 |   |     |                11,142,362 |   |     |  5,261,192 |   |     |  5,881,170 |   |
| Loss from operations                          |     |                  (6,016,088 | ) |     | (3,553,834 | ) |     | (2,462,254 | ) |     |